ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.530G>A (p.Arg177Gln)

gnomAD frequency: 0.00006  dbSNP: rs371481933
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154729 SCV000204409 uncertain significance not specified 2013-08-09 criteria provided, single submitter clinical testing The Arg177Gln variant in JUP has not been reported in individuals with cardiomyo pathy, but has been identified in 2/8600 of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). Computation al analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhe n2, and SIFT) suggest that the Arg177Gln variant may not impact the protein, tho ugh this information is not predictive enough to rule out pathogenicity. Additio nal information is needed to fully assess the clinical significance of the Arg17 7Gln variant.
Ambry Genetics RCV000621366 SCV000738210 likely benign Cardiovascular phenotype 2021-11-18 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV000702831 SCV000831702 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2024-12-23 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 177 of the JUP protein (p.Arg177Gln). This variant is present in population databases (rs371481933, gnomAD 0.006%). This missense change has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257). ClinVar contains an entry for this variant (Variation ID: 178044). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV002243826 SCV002513133 uncertain significance not provided 2022-04-25 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27532257, 31402444)
Fulgent Genetics, Fulgent Genetics RCV000702831 SCV002814385 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2024-05-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.